Endevica Bio creates first-in-class peptide drug candidates. Endevica Bio’s technology platform, protected by a family of patents and pending applications, allows for the modification of peptides to modulate activity of important drug targets behind the blood-brain barrier.

 

Industries
Biotech
Pharma



Office Locations
Northbrook
Contact Information
Dan Marks
Endevica Bio
[email protected]
Making a selection with these dropdown will cause content on this page to change. News listings will update as each option is selected.

Latest

Oct 02, 2025, 12:00 ET Endevica Bio Unveils Differentiated Mechanism for Durable Weight Loss in Obesity

Endevica Bio, a clinical-stage biotechnology company pioneering peptide therapeutics for metabolic diseases, announced a major scientific...

Apr 17, 2025, 15:38 ET Endevica Bio Announces First Patient Dosing in Phase 2 Trial in Patients with Stage 4 Metastatic Colorectal Cancer

Endevica Bio, a privately held company developing first-in-class peptide drug candidates, announced today the dose administration for the first...

Dec 20, 2024, 08:30 ET Endevica Bio to Start Phase 2 Clinical Trial of Drug to Prevent Weight Loss in Cancer Patients

Endevica Bio, a privately held company developing first-in-class peptide drug candidates, today announced the start of a Phase 2 clinical trial of...

Nov 12, 2024, 12:19 ET Endevica Bio Drug Candidate Shows Promise for Alleviating Chemotherapy-Induced Anorexia and Weight Loss, Study Shows

Endevica Bio's experimental peptide to prevent weight loss associated with cachexia improved the appetite and preserved lean mass and fat mass in...

Nov 01, 2024, 10:38 ET Endevica Bio Spins Off New Company to Develop Weight Loss Drug

Endevica Bio, a privately held company developing first-in-class peptide drug candidates, today announced the spin-off of a newly created company...

Apr 23, 2024, 08:03 ET Endevica Bio drug candidate shows success in weight loss in new study

Endevica Bio, a company developing first-in-class peptide drug candidates, announced its novel weight-loss treatment was successful in a recent...

Journalists and Bloggers

The news you need, when you need it.

Join PR Newswire for Journalists to access all of the free services designated to make your job easier.

In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.

LEARN MORE
Making a selection with these dropdown will cause content on this page to change. News listings will update as each option is selected.